Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Autoimmune Disorders

  Free Subscription


Articles published in J Neurol

Retrieve available abstracts of 128 articles:
HTML format
Text format



Single Articles


    January 2012
  1. FERNANDEZ O , Oreja-Guevara C, Arroyo R, Izquierdo G, et al
    Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.
    J Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. BERNO S , Coenen M, Leib A, Cieza A, et al
    Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians.
    J Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. TURAKA K , Bryan JS
    Does fingolimod in multiple sclerosis patients cause macular edema?
    J Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  4. FANCHAMPS MH , Gensicke H, Kuhle J, Kappos L, et al
    Screening for balance disorders in mildly affected multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  5. PATRUCCO L , Rojas JI, Cristiano E
    Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. ROMI F , Suzuki S, Suzuki N, Petzold A, et al
    Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. MELIN A , Outteryck O, Collongues N, Zephir H, et al
    Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  8. RATCHFORD JN , Endres CJ, Hammoud DA, Pomper MG, et al
    Decreased microglial activation in MS patients treated with glatiramer acetate.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. JALLOULI M , Saadoun D, Eymard B, Leroux G, et al
    The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. JACOBS JV , Kasser SL
    Effects of dual tasking on the postural performance of people with and without multiple sclerosis: a pilot study.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  11. YUKI N , Kokubun N, Kuwabara S, Sekiguchi Y, et al
    Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. STRUPP M
    Multiple sclerosis: iron mapping, predicting response to interferon-beta and effects of oral teriflunomide.
    J Neurol. 2011;258:2302-4.
    PubMed     Text format     Related articles   



    November 2011
  13. LIANG AL , Vavasour IM, Madler B, Traboulsee AL, et al
    Short-term stability of T (1) and T (2) relaxation measures in multiple sclerosis normal appearing white matter.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  14. CATS EA , Bertens AS, Veldink JH, van den Berg LH, et al
    Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  15. HO JK , Sadiq SA
    Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



    October 2011
  16. D'HOOGHE MB , Haentjens P, Nagels G, D'Hooghe T, et al
    Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  17. SIVERA R , Martin N, Bosca I, Sevilla T, et al
    Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. MAGRANER MJ , Coret F, Navarre A, Bosca I, et al
    Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study.
    J Neurol. 2011;258:1805-11.
    PubMed     Text format     Related articles    Abstract available



  19. PACHECO-CUELLAR G , Gonzalez-Huerta LM, Valdes-Miranda JM, Pelaez-Gonzalez H, et al
    Hereditary sensory and autonomic neuropathy II due to novel mutation in the HSN2 gene in Mexican families.
    J Neurol. 2011;258:1890-2.
    PubMed     Text format     Related articles   



  20. GNANAPAVAN S , Vincent A, Giovannoni G
    Surviving stiff-person syndrome: a case report.
    J Neurol. 2011;258:1898-900.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  21. BLADH S , Nilsson MH, Hariz GM, Westergren A, et al
    Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. MCLEOD JG , Hammond SR, Kurtzke JF
    Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. ECKSTEIN C , Saidha S, Levy M
    A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. LAUVSNES MB , Omdal R
    Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  25. HAYTON T , Furby J, Smith KJ, Altmann DR, et al
    Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  26. O'CONNOR K , Weinstock-Guttman B, Carl E, Kilanowski C, et al
    Patterns of dietary and herbal supplement use by multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  27. HAYTON T , Furby J, Smith KJ, Altmann DR, et al
    Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. PEVZNER A , Schoser B, Peters K, Cosma NC, et al
    Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. NEUTEBOOM RF , Janssens AC, Siepman TA, Hoppenbrouwers IA, et al
    Pregnancy in multiple sclerosis: clinical and self-report scales.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  30. ALEXOPOULOS H , Kosmidis ML, Dalmau J, Dalakas MC, et al
    Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies.
    J Neurol. 2011;258:1568-70.
    PubMed     Text format     Related articles   



    July 2011
  31. ZITTEL S , Bester M, Gerloff C, Munchau A, et al
    Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  32. LEHMANN HC , Macht S, Jander S, Hartung HP, et al
    Guillain-Barre syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  33. SUTTER R , Mengiardi B, Benz D, Heijnen I, et al
    Facial nerve palsy and anti-Ku autoantibodies.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  34. BATISTA S , Zivadinov R, Hoogs M, Bergsland N, et al
    Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. CHEN YT , Chang Y, Chiu HC, Yeh JH, et al
    Psychosocial aspects in myasthenic patients treated by plasmapheresis.
    J Neurol. 2011;258:1240-6.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  36. PALING D , Golay X, Wheeler-Kingshott C, Kapoor R, et al
    Energy failure in multiple sclerosis and its investigation using MR techniques.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. BUCK D , Hemmer B
    Treatment of multiple sclerosis: current concepts and future perspectives.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  38. SEKIGUCHI T , Ishibashi S, Kubodera T, Fukabori J, et al
    Anhidrosis associated with hypothalamic lesions related to anti-aquaporin 4 autoantibody.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  39. DURANT C , Martin J, Godmer P, Moreau A, et al
    Exceptional osseous and meningeal spinal localization of ANCA-associated granulomatous vasculitis with hypertrophic spinal pachymeningitis.
    J Neurol. 2011;258:1172-3.
    PubMed     Text format     Related articles   



    May 2011
  40. SEPULVEDA M , Munteis E, Rubio MA, Pascual J, et al
    Adult onset Pompe disease associated with multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  41. YALDIZLI O , Glassl S, Sturm D, Papadopoulou A, et al
    Fatigue and progression of corpus callosum atrophy in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  42. SCUDERI F , Alboini PE, Bartoccioni E, Evoli A, et al
    BAFF serum levels in myasthenia gravis: effects of therapy.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  43. FJELDSTAD AS , McDaniel J, Witman MA, Ives SJ, et al
    Vascular function and multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  44. DUDDY M , Haghikia A, Cocco E, Eggers C, et al
    Managing MS in a changing treatment landscape.
    J Neurol. 2011;258:728-39.
    PubMed     Text format     Related articles    Abstract available



  45. TSCHAMPA HJ , Greschus S, Vinahl M, Urbach H, et al
    MS-like presentation of Alexander disease with multifocal lesions and oligoclonal bands.
    J Neurol. 2011;258:935-7.
    PubMed     Text format     Related articles   



  46. JARIUS S , Wandinger KP, Platzer S, Wildemann B, et al
    Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence for cross-reactivity in neuromyelitis optica. A study on 114 patients.
    J Neurol. 2011;258:929-31.
    PubMed     Text format     Related articles   



    April 2011
  47. CAUDIE C , Quittard Pinon A, Taravel D, Sivadon-Tardy V, et al
    Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barre syndrome patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  48. STRUPP M
    Multiple sclerosis II: new diagnostic criteria, association with smoking and effects of cannabis on cognitive function.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  49. NOCITI V , Batocchi AP, Luigetti M, Conte A, et al
    Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  50. NA SJ , So SH, Lee KO, Choi YC, et al
    Elevated serum level of interleukin-32alpha in the patients with myasthenia gravis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  51. INVERNIZZI P , Bertolasi L, Bianchi MR, Turatti M, et al
    Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  52. HEALY B , Chitnis T, Engler D
    Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  53. MORROW SA , Jurgensen S, Forrestal F, Munchauer FE, et al
    Erratum to: Effects of acute relapses on neuropsychological status in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  54. MCNAMARA PH , Costelloe L, Langan Y, Redmond J, et al
    Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging.
    J Neurol. 2011;258:702-3.
    PubMed     Text format     Related articles   



  55. NAKAYAMA-ICHIYAMA S , Yokote T, Hiraoka N, Iwaki K, et al
    Multiple organ injury associated with neuromyelitis optica spectrum disorder in a low-grade B-cell lymphoma suspected of being follicular lymphoma.
    J Neurol. 2011;258:691-3.
    PubMed     Text format     Related articles   



    March 2011
  56. REIS A , Mateus C, Macario MC, de Abreu JR, et al
    Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  57. JOZEFOWICZ-KORCZYNSKA M , Pajor AM
    Evaluation of the smooth pursuit tests in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  58. PROCHNOW D , Donell J, Schafer R, Jorgens S, et al
    Alexithymia and impaired facial affect recognition in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  59. FAREZ MF , Correale J
    Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  60. STRUPP M
    Multiple sclerosis: sun exposure and vitamin D, ultra-high-field imaging, and B cell clones in the meninges.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  61. TANG Y , Chu C, Lin MT, Wei G, et al
    Hashimoto's encephalopathy mimicking spinocerebellar ataxia.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  62. HAVLA J , Gerdes LA, Meinl I, Krumbholz M, et al
    De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. SIMON KC , Munger KL, Kraft P, Hunter DJ, et al
    Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  64. KOUTSIS G , Karadima G, Floroskufi P, Sfagos C, et al
    The rs10492972 KIF1B polymorphism and disease progression in Greek patients with multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  65. EDWARDS LJ , Sharrack B, Ismail A, Tumani H, et al
    Central inflammation versus peripheral regulation in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  66. MORROW SA , Jurgensen S, Forrestal F, Munchauer FE, et al
    Effects of acute relapses on neuropsychological status in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. COENEN M , Cieza A, Freeman J, Khan F, et al
    The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. CORDA D , Deiana GA, Mulargia M, Pirastru MI, et al
    Familial autoimmune MuSK positive myasthenia gravis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  69. AKMAN-DEMIR G , Tuzun E, Waters P, Icoz S, et al
    Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
    J Neurol. 2011;258:464-70.
    PubMed     Text format     Related articles    Abstract available



  70. CISSE FA , Antoine JC, Pillet S, Jousserand G, et al
    Acute hemorrhagic leukoencephalopathy associated with influenza A (H1N1) virus.
    J Neurol. 2011;258:513-4.
    PubMed     Text format     Related articles   



    February 2011
  71. MENGE T , Hartung HP, Kieseier BC
    Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now : Commentary to: 10.1007/s00415-010-5844-5 "One-year evaluation of factors affecting the biological activity of interferon beta in multiple scl
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  72. MCNICHOLAS N , Chataway J
    Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  73. BARBI F , Ariatti A, Funakoshi K, Meacci M, et al
    Parvovirus B19 infection antedating Guillain-Barre' syndrome variant with prominent facial diplegia.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  74. LEBRUN C , Vermersch P, Brassat D, Defer G, et al
    Cancer and multiple sclerosis in the era of disease-modifying treatments.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. WIPFLER P , Pilz G, Broussalis E, Golaszewski SM, et al
    Acute pulmonary edema caused by a multiple sclerosis relapse.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  76. MORI F , Ljoka C, Magni E, Codeca C, et al
    Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  77. SAKAGUCHI H , Yamashita S, Miura A, Hirahara T, et al
    A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot-Marie-Tooth disease.
    J Neurol. 2011;258:284-90.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  78. MCLEOD JG , Hammond SR, Kurtzke JF
    Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  79. VALENTINO P , Nistico R, Pirritano D, Bilotti G, et al
    Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  80. JUDICA E , Martinelli Boneschi F, Ungaro D, Comola M, et al
    Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  81. CENACCHI G , Papa V, Fanin M, Pegoraro E, et al
    Erratum to: Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.
    J Neurol. 2011.
    PubMed     Text format     Related articles   



  82. ARGYRIOU AA , Iconomou G, Ifanti AA, Karanasios P, et al
    Religiosity and its relation to quality of life in primary caregivers of patients with multiple sclerosis: a case study in Greece.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  83. AXELSSON M , Malmestrom C, Nilsson S, Haghighi S, et al
    Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  84. HARAN M
    In response to "current approach to seronegative myasthenia" by Z. Argov.
    J Neurol. 2011;258:164-5.
    PubMed     Text format     Related articles   



  85. ARGOV Z
    Current approach to seronegative myasthenia.
    J Neurol. 2011;258:14-8.
    PubMed     Text format     Related articles   



  86. STOREY K , Matej R, Rusina R
    Unusual association of seronegative, nonparaneoplastic limbic encephalitis and relapsing polychondritis in a patient with history of thymectomy for myasthenia: a case study.
    J Neurol. 2011;258:159-61.
    PubMed     Text format     Related articles   



    December 2010
  87. MALUCCHI S , Gilli F, Caldano M, Sala A, et al
    One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  88. ZAARAOUI W , Reuter F, Rico A, Faivre A, et al
    Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  89. LU MO , Zhu J
    The role of cytokines in Guillain-Barre syndrome.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  90. STRUPP M
    News on multiple sclerosis: induction of immune tolerance, a biomarker for predicting disease activity, and CSF ferritin levels.
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  91. CENACCHI G , Valentina P, Marina F, Elena P, et al
    Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  92. SACCO R , Bussman R, Oesch P, Kesselring J, et al
    Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  93. DISANTO G , Ramagopalan SV, Para AE, Handunnetthi L, et al
    The emerging role of vitamin D binding protein in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  94. ANDERSON G , Meyer D, Herrman CE, Sheppard C, et al
    Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study.
    J Neurol. 2010;257:1917-23.
    PubMed     Text format     Related articles    Abstract available



  95. PETEREIT HF , Reske D, Tumani H, Jarius S, et al
    Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
    J Neurol. 2010;257:1855-63.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  96. ZANDI MS , Irani SR, Lang B, Waters P, et al
    Disease-relevant autoantibodies in first episode schizophrenia.
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  97. MACMANUS DG , Miller DH, Kappos L, Gold R, et al
    BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  98. MUNGER KL , Chitnis T, Frazier AL, Giovannucci E, et al
    Dietary intake of vitamin D during adolescence and risk of multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  99. AKBAR N , Honarmand K, Kou N, Feinstein A, et al
    Validity of a computerized version of the Symbol Digit Modalities Test in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  100. ZWIBEL H , Pardo G, Smith S, Denney D, et al
    A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  101. GOERTZ C , Wegner C, Bruck W, Berlit P, et al
    Primary angiitis of the CNS with pure spinal cord involvement: a case report.
    J Neurol. 2010;257:1762-4.
    PubMed     Text format     Related articles   



  102. SENA A , Bendtzen K, Cascais MJ, Pedrosa R, et al
    Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta.
    J Neurol. 2010;257:1703-7.
    PubMed     Text format     Related articles    Abstract available



  103. SELLNER J , Schirmer L, Hemmer B, Muhlau M, et al
    The radiologically isolated syndrome: take action when the unexpected is uncovered?
    J Neurol. 2010;257:1602-11.
    PubMed     Text format     Related articles    Abstract available



  104. FLACHENECKER P , Khil L, Bergmann S, Kowalewski M, et al
    Development and pilot phase of a European MS register.
    J Neurol. 2010;257:1620-7.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  105. HELLWIG K , Gold R
    Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  106. KEARNEY H , Murray B, Kavanagh E, O'Rourke K, et al
    Autoimmune encephalopathy presenting as a 'posterior circulation stroke'
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  107. MORGANTE F , Dattola V, Crupi D, Russo M, et al
    Is central fatigue in multiple sclerosis a disorder of movement preparation?
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  108. LI Y , Zeng C, Luo T
    Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  109. HONARMAND K , Akbar N, Kou N, Feinstein A, et al
    Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  110. DI FILIPPO M , Luchetti E, Prontera P, Donti E, et al
    Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  111. HANE A , Bargetzi M, Hewer E, Bruehlmeier M, et al
    Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.
    J Neurol. 2010.
    PubMed     Text format     Related articles   



  112. VISSER NA , Braun KP, Leijten FS, van Nieuwenhuizen O, et al
    Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  113. BLASEL S , Pfeilschifter W, Jansen V, Mueller K, et al
    Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  114. HOROWSKI S , Zettl UK, Benecke R, Walter U, et al
    Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  115. MERKELBACH S , Schulz H, Kolmel HW, Gora G, et al
    Fatigue, sleepiness, and physical activity in patients with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  116. NESSLER S , Bruck W
    Advances in multiple sclerosis research in 2009.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  117. MARCEL C , Anheim M, Flamand-Rouviere C, Heran F, et al
    Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.
    J Neurol. 2010;257:1369-72.
    PubMed     Text format     Related articles    Abstract available



  118. NAEIJE G , Legros B, de Beyl DZ
    Neuromuscular junction border conflict.
    J Neurol. 2010;257:1402-3.
    PubMed     Text format     Related articles   



    July 2010
  119. DHUNGANA S , Waters P, Ismail A, Woodroofe N, et al
    Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension.
    J Neurol. 2010;257:1211-2.
    PubMed     Text format     Related articles   



  120. THUMEN A , Moser A
    An uncommon paraneoplastic Ri-positive opsoclonus-myoclonus-like syndrome and stiff-person syndrome with elevated glutamate/GABA ratio in the cerebrospinal fluid after breast cancer.
    J Neurol. 2010;257:1215-7.
    PubMed     Text format     Related articles   



    June 2010
  121. SAIDHA S , Murphy S, Ronayne A, McCarthy P, et al
    Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.
    J Neurol. 2010;257:1035-8.
    PubMed     Text format     Related articles   



  122. ALVARENGA MP , Thuler LC, Neto SP, Vasconcelos CC, et al
    The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.
    J Neurol. 2010;257:992-8.
    PubMed     Text format     Related articles    Abstract available



  123. PENG F , Zhong X, Deng X, Qiu W, et al
    Serum uric acid levels and neuromyelitis optica.
    J Neurol. 2010;257:1021-6.
    PubMed     Text format     Related articles    Abstract available



  124. FLET L , Polard E, Guillard O, Leray E, et al
    3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.
    J Neurol. 2010;257:937-46.
    PubMed     Text format     Related articles    Abstract available



  125. MARSH EA , Hirst CL, Llewelyn JG, Cossburn MD, et al
    Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.
    J Neurol. 2010;257:913-9.
    PubMed     Text format     Related articles    Abstract available



  126. KIM SH , Kim SM, Vincent A, Ahn SW, et al
    Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
    J Neurol. 2010;257:920-5.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  127. KRAEMER M , Berlit P
    Primary central nervous system vasculitis and moyamoya disease: similarities and differences.
    J Neurol. 2010;257:816-9.
    PubMed     Text format     Related articles    Abstract available



  128. SASTRE-GARRIGA J , Tintore M, Nos C, Tur C, et al
    Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
    J Neurol. 2010;257:742-6.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: